Nuntius Therapeutics
Cell-specific genetic medicines
London, United Kingdom · Founded 2021
- Headquarters
- London
- Employees
- 1–10
- Founded
- 2021
- Website
- nuntiustx.com
- Last Round
- Pre-SeedJan 2021
- Rounds
- 1
About
Cell-specific genetic medicines
Summary
Nuntius Therapeutics is a Biotech company based in London, United Kingdom, founded in 2021. Its most recent funding was a Pre-Seed round in Jan 2021. Investors include Asymmetry Ventures, Backed and FoundersX Ventures.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2021
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Global contract research organization providing comprehensive drug development and laboratory ser...